Tengion Secures $1,000,000 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    3929 Westpoint Blvd Winston-Salem, NC 27103 USA
  • Company Description
    Tengion (NASDAQ: TNGN) is a leader in developing autologous neo-organs and tissues, such as bladders, that are derived from the patient’s own (autologous) cells. Tengion’s proprietary approach to regenerative medicine has the potential to enable people with organ and tissue failure to lead healthier lives without donor transplants or the side effects of current therapies.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy